Livzon Pharmaceutical Group Inc. (1513.HK)
HKD 26.9
(-0.37%)
HKD 26.9
(-0.37%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 7.96 Billion CNY | -2.49% |
| 2022 | 8.16 Billion CNY | 4.58% |
| 2021 | 7.81 Billion CNY | 14.08% |
| 2020 | 6.84 Billion CNY | 14.25% |
| 2019 | 5.99 Billion CNY | 8.94% |
| 2018 | 5.5 Billion CNY | 0.97% |
| 2017 | 5.44 Billion CNY | 11.09% |
| 2016 | 4.9 Billion CNY | 21.23% |
| 2015 | 4.04 Billion CNY | 18.93% |
| 2014 | 3.4 Billion CNY | 16.32% |
| 2013 | 2.92 Billion CNY | 23.18% |
| 2012 | 2.37 Billion CNY | 34.5% |
| 2011 | 1.76 Billion CNY | 22.55% |
| 2010 | 1.44 Billion CNY | 5.6% |
| 2009 | 1.36 Billion CNY | 44.73% |
| 2008 | 942.32 Million CNY | 21.67% |
| 2007 | 774.48 Million CNY | 10.01% |
| 2006 | 704.03 Million CNY | -2.21% |
| 2005 | 719.91 Million CNY | -5.68% |
| 2004 | 763.27 Million CNY | -14.94% |
| 2003 | 897.29 Million CNY | 26.96% |
| 2002 | 706.73 Million CNY | 7.99% |
| 2001 | 654.42 Million CNY | 20.35% |
| 2000 | 543.79 Million CNY | 6.42% |
| 1999 | 511 Million CNY | 60.31% |
| 1998 | 318.75 Million CNY | 7.65% |
| 1997 | 296.1 Million CNY | 20.59% |
| 1996 | 245.55 Million CNY | 13.56% |
| 1995 | 216.22 Million CNY | 22.76% |
| 1994 | 176.13 Million CNY | 0.0% |
| 1992 | 127.87 Million CNY | 8.95% |
| 1991 | 117.37 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 2.09 Billion CNY | 17.0% |
| 2024 Q2 | 2.04 Billion CNY | -2.41% |
| 2024 Q3 | 1.83 Billion CNY | -10.45% |
| 2023 Q3 | 1.88 Billion CNY | -11.72% |
| 2023 Q1 | 2.15 Billion CNY | 10.25% |
| 2023 FY | 7.96 Billion CNY | -2.49% |
| 2023 Q2 | 2.13 Billion CNY | -0.83% |
| 2023 Q4 | 1.79 Billion CNY | -4.89% |
| 2022 Q1 | 2.3 Billion CNY | 39.9% |
| 2022 Q3 | 2.1 Billion CNY | 16.34% |
| 2022 Q4 | 1.95 Billion CNY | -7.24% |
| 2022 Q2 | 1.8 Billion CNY | -21.38% |
| 2022 FY | 8.16 Billion CNY | 4.58% |
| 2021 Q1 | 2.22 Billion CNY | 38.8% |
| 2021 Q2 | 1.88 Billion CNY | -15.42% |
| 2021 Q3 | 2.05 Billion CNY | 9.13% |
| 2021 Q4 | 1.64 Billion CNY | -19.97% |
| 2021 FY | 7.81 Billion CNY | 14.08% |
| 2020 Q3 | 1.88 Billion CNY | 8.3% |
| 2020 FY | 6.84 Billion CNY | 14.25% |
| 2020 Q1 | 1.62 Billion CNY | 27.59% |
| 2020 Q2 | 1.73 Billion CNY | 6.91% |
| 2020 Q4 | 1.6 Billion CNY | -14.7% |
| 2019 Q1 | 1.69 Billion CNY | 39.4% |
| 2019 FY | 5.99 Billion CNY | 8.94% |
| 2019 Q2 | 1.5 Billion CNY | -10.92% |
| 2019 Q3 | 1.51 Billion CNY | 0.36% |
| 2019 Q4 | 1.27 Billion CNY | -15.96% |
| 2018 Q1 | 1.52 Billion CNY | 27.3% |
| 2018 Q4 | 1.21 Billion CNY | -14.93% |
| 2018 Q3 | 1.42 Billion CNY | 7.34% |
| 2018 FY | 5.5 Billion CNY | 0.97% |
| 2018 Q2 | 1.33 Billion CNY | -12.7% |
| 2017 Q4 | 1.19 Billion CNY | -18.97% |
| 2017 Q2 | 1.37 Billion CNY | -1.34% |
| 2017 Q3 | 1.47 Billion CNY | 7.41% |
| 2017 Q1 | 1.39 Billion CNY | 15.68% |
| 2017 FY | 5.44 Billion CNY | 11.09% |
| 2016 Q4 | 1.2 Billion CNY | -4.97% |
| 2016 FY | 4.9 Billion CNY | 21.23% |
| 2016 Q3 | 1.26 Billion CNY | -2.89% |
| 2016 Q2 | 1.3 Billion CNY | 16.44% |
| 2016 Q1 | 1.12 Billion CNY | 7.25% |
| 2015 Q2 | 944.77 Million CNY | -1.69% |
| 2015 Q4 | 1.04 Billion CNY | -4.26% |
| 2015 Q3 | 1.09 Billion CNY | 15.69% |
| 2015 Q1 | 961.02 Million CNY | 12.45% |
| 2015 FY | 4.04 Billion CNY | 18.93% |
| 2014 FY | 3.4 Billion CNY | 16.32% |
| 2014 Q4 | 854.59 Million CNY | -6.73% |
| 2014 Q3 | 916.29 Million CNY | 3.12% |
| 2014 Q2 | 888.61 Million CNY | 19.79% |
| 2014 Q1 | 741.82 Million CNY | -13.26% |
| 2013 Q4 | 855.23 Million CNY | 19.54% |
| 2013 Q1 | 657.62 Million CNY | 7.89% |
| 2013 Q3 | 715.41 Million CNY | 2.82% |
| 2013 FY | 2.92 Billion CNY | 23.18% |
| 2013 Q2 | 695.79 Million CNY | 5.8% |
| 2012 Q3 | 628.08 Million CNY | 5.25% |
| 2012 Q1 | 539.51 Million CNY | 3.82% |
| 2012 FY | 2.37 Billion CNY | 34.5% |
| 2012 Q2 | 596.72 Million CNY | 10.6% |
| 2012 Q4 | 609.5 Million CNY | -2.96% |
| 2011 FY | 1.76 Billion CNY | 22.55% |
| 2011 Q1 | 387.56 Million CNY | -3.03% |
| 2011 Q2 | 406.78 Million CNY | 4.96% |
| 2011 Q3 | 450.94 Million CNY | 10.86% |
| 2011 Q4 | 519.68 Million CNY | 15.24% |
| 2010 Q3 | 353.54 Million CNY | -0.42% |
| 2010 FY | 1.44 Billion CNY | 5.6% |
| 2010 Q1 | 331.97 Million CNY | -9.41% |
| 2010 Q2 | 355.02 Million CNY | 6.94% |
| 2010 Q4 | 399.68 Million CNY | 13.05% |
| 2009 Q4 | 366.47 Million CNY | 5.96% |
| 2009 FY | 1.36 Billion CNY | 44.73% |
| 2009 Q3 | 345.84 Million CNY | -6.53% |
| 2009 Q2 | 370 Million CNY | 31.42% |
| 2009 Q1 | 281.54 Million CNY | 19.53% |
| 2008 Q3 | 226.59 Million CNY | -13.92% |
| 2008 Q2 | 263.23 Million CNY | 21.33% |
| 2008 Q1 | 216.95 Million CNY | -4.59% |
| 2008 FY | 942.32 Million CNY | 21.67% |
| 2008 Q4 | 235.54 Million CNY | 3.95% |
| 2007 Q1 | 187.82 Million CNY | -5.85% |
| 2007 Q4 | 227.38 Million CNY | 17.01% |
| 2007 Q3 | 194.32 Million CNY | 17.8% |
| 2007 Q2 | 164.95 Million CNY | -12.18% |
| 2007 FY | 774.48 Million CNY | 10.01% |
| 2006 Q4 | 199.48 Million CNY | 21.12% |
| 2006 Q3 | 164.7 Million CNY | -4.07% |
| 2006 Q2 | 171.69 Million CNY | 2.11% |
| 2006 Q1 | 168.14 Million CNY | -5.29% |
| 2006 FY | 704.03 Million CNY | -2.21% |
| 2005 FY | 719.91 Million CNY | -5.68% |
| 2005 Q4 | 177.53 Million CNY | 7.89% |
| 2005 Q3 | 164.55 Million CNY | -14.17% |
| 2005 Q2 | 191.73 Million CNY | 3.04% |
| 2005 Q1 | 186.08 Million CNY | -1.73% |
| 2004 Q4 | 189.36 Million CNY | 5.72% |
| 2004 FY | 763.27 Million CNY | -14.94% |
| 2004 Q1 | 203.76 Million CNY | -2.77% |
| 2004 Q2 | 191.03 Million CNY | -6.24% |
| 2004 Q3 | 179.11 Million CNY | -6.24% |
| 2003 Q3 | 197.09 Million CNY | -29.97% |
| 2003 Q4 | 209.57 Million CNY | 6.33% |
| 2003 FY | 897.29 Million CNY | 26.96% |
| 2003 Q1 | 220.99 Million CNY | 11.13% |
| 2003 Q2 | 281.44 Million CNY | 27.35% |
| 2002 Q3 | 182.84 Million CNY | -3.63% |
| 2002 Q2 | 189.73 Million CNY | 40.23% |
| 2002 FY | 706.73 Million CNY | 7.99% |
| 2002 Q1 | 135.29 Million CNY | 0.0% |
| 2002 Q4 | 198.86 Million CNY | 8.76% |
| 2001 FY | 654.42 Million CNY | 20.35% |
| 2000 FY | 543.79 Million CNY | 6.42% |
| 1999 FY | 511 Million CNY | 60.31% |
| 1998 FY | 318.75 Million CNY | 7.65% |
| 1997 FY | 296.1 Million CNY | 20.59% |
| 1996 FY | 245.55 Million CNY | 13.56% |
| 1995 FY | 216.22 Million CNY | 22.76% |
| 1994 FY | 176.13 Million CNY | 0.0% |
| 1992 FY | 127.87 Million CNY | 8.95% |
| 1991 FY | 117.37 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 167.43 Million HKD | -4656.782% |
| Grand Pharmaceutical Group Limited | 6.52 Billion HKD | -22.08% |
| Extrawell Pharmaceutical Holdings Limited | 28.77 Million HKD | -27574.919% |
| Wai Yuen Tong Medicine Holdings Limited | 394.81 Million HKD | -1917.301% |
| Qianhai Health Holdings Limited | -35.6 Million HKD | 22470.488% |
| Lee's Pharmaceutical Holdings Limited | 551.31 Million HKD | -1344.659% |
| Essex Bio-Technology Limited | 1.53 Billion HKD | -417.417% |
| Tongfang Kontafarma Holdings Limited | 471.29 Million HKD | -1589.943% |
| PuraPharm Corporation Limited | 216.62 Million HKD | -3576.592% |
| SSY Group Limited | 3.48 Billion HKD | -128.265% |
| JBM (Healthcare) Limited | 319.41 Million HKD | -2393.477% |
| Jacobson Pharma Corporation Limited | 620.47 Million HKD | -1183.624% |
| China Resources Pharmaceutical Group Limited | 43.36 Billion HKD | 81.634% |